Compile Data Set for Download or QSAR
maximum 50k data
Found 105 with your filter
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302692((S)-4-(6-(4-(azetidine-1-carbonyl)piperidin-1-yl)-...)
Affinity DataIC50:  230nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302690((S)-5-oxo-5-(4-(pentyloxycarbonyl)piperazin-1-yl)-...)
Affinity DataIC50:  270nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302695((S)-5-(4-(butoxycarbonyl)piperazin-1-yl)-4-(6-(4-(...)
Affinity DataIC50:  280nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302698((S)-4-(6-(4-(dimethylcarbamoyl)piperidin-1-yl)-2-p...)
Affinity DataIC50:  370nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302691((S)-5-(4-(butoxycarbonyl)piperazin-1-yl)-5-oxo-4-(...)
Affinity DataIC50:  390nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302694((S)-4-(6-(4-(diethylcarbamoyl)piperidin-1-yl)-2-ph...)
Affinity DataIC50:  400nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302719((S)-4-(6-(4-(2-(dimethylamino)ethyl)piperidin-1-yl...)
Affinity DataIC50:  400nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302697((S)-5-(4-(butoxycarbonyl)piperazin-1-yl)-4-(4-(4-(...)
Affinity DataIC50:  490nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302729((S)-4-(6-(4-(aminomethyl)piperidin-1-yl)-2-phenylp...)
Affinity DataIC50:  490nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302629((S)-5-oxo-5-(4-(pentyloxycarbonyl)piperazin-1-yl)-...)
Affinity DataIC50:  510nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302636((S)-4-(6-(4-(2-(dimethylamino)-2-oxoethyl)piperazi...)
Affinity DataIC50:  530nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302722((S)-5-oxo-5-(4-(pentyloxycarbonyl)piperazin-1-yl)-...)
Affinity DataIC50:  560nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302721((S)-4-(6-(4-(2-aminoethyl)piperidin-1-yl)-2-phenyl...)
Affinity DataIC50:  620nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302630((S)-5-(4-(butoxycarbonyl)piperazin-1-yl)-5-oxo-4-(...)
Affinity DataIC50:  660nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302701((S)-4-(6-(4-carbamoylpiperidin-1-yl)-2-phenylpyrim...)
Affinity DataIC50:  690nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302646((S)-4-(6-(4-aminopiperidin-1-yl)-2-phenylpyrimidin...)
Affinity DataIC50:  720nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302727((S)-4-(6-(4-((methylamino)methyl)piperidin-1-yl)-2...)
Affinity DataIC50:  740nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302725((S)-4-(6-(4-((ethylamino)methyl)piperidin-1-yl)-2-...)
Affinity DataIC50:  770nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302728((S)-4-(4-(4-(aminomethyl)piperidin-1-yl)-6-phenylp...)
Affinity DataIC50:  770nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302626((S)-4-(6-(4-morpholinopiperidin-1-yl)-2-phenylpyri...)
Affinity DataIC50:  780nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302718((S)-5-oxo-5-(4-(pentyloxycarbonyl)piperazin-1-yl)-...)
Affinity DataIC50:  810nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302723((4S)-4-[(6-{4-[(diethylamino)methyl]piperidin-1-yl...)
Affinity DataIC50:  860nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302627((S)-5-(4-(butoxycarbonyl)piperazin-1-yl)-4-(6-(4-m...)
Affinity DataIC50:  880nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302696((S)-4-(6-(4-(ethylcarbamoyl)piperidin-1-yl)-2-phen...)
Affinity DataIC50:  930nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302640((S)-4-(6-(4-carbamoylpiperazin-1-yl)-2-phenylpyrim...)
Affinity DataIC50:  940nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302685((S)-4-(6-(4-(2-(azetidin-1-yl)-2-oxoethyl)piperidi...)
Affinity DataIC50:  1.00E+3nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302634((S)-5-oxo-4-(6-(4-(2-oxo-2-(pyrrolidin-1-yl)ethyl)...)
Affinity DataIC50:  1.10E+3nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302688((S)-4-(6-(4-(2-(methylamino)-2-oxoethyl)piperidin-...)
Affinity DataIC50:  1.10E+3nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302724((S)-4-(4-(4-((ethylamino)methyl)piperidin-1-yl)-6-...)
Affinity DataIC50:  1.20E+3nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302667((S)-5-(4-(butoxycarbonyl)piperazin-1-yl)-5-oxo-4-(...)
Affinity DataIC50:  1.20E+3nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302705((S)-5-(4-(butoxycarbonyl)piperazin-1-yl)-4-(6-(4-(...)
Affinity DataIC50:  1.20E+3nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302693((S)-4-(4-(4-(diethylcarbamoyl)piperidin-1-yl)-6-ph...)
Affinity DataIC50:  1.30E+3nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302726((S)-4-(4-(4-((methylamino)methyl)piperidin-1-yl)-6...)
Affinity DataIC50:  1.30E+3nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302711((S)-4-(6-(4-(2-hydroxyethoxy)piperidin-1-yl)-2-phe...)
Affinity DataIC50:  1.30E+3nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302669((S)-5-(4-(butoxycarbonyl)piperazin-1-yl)-5-oxo-4-(...)
Affinity DataIC50:  1.30E+3nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302644((S)-5-oxo-5-(4-(pentyloxycarbonyl)piperazin-1-yl)-...)
Affinity DataIC50:  1.30E+3nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302648((S)-4-(6-(4-methylpiperazin-1-yl)-2-phenylpyrimidi...)
Affinity DataIC50:  1.40E+3nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302713((S)-4-(6-(4-(2-methoxyethoxy)piperidin-1-yl)-2-phe...)
Affinity DataIC50:  1.40E+3nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302720((S)-4-(4-(4-(2-aminoethyl)piperidin-1-yl)-6-phenyl...)
Affinity DataIC50:  1.40E+3nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302642((S)-4-(6-(4-acetylpiperazin-1-yl)-2-phenylpyrimidi...)
Affinity DataIC50:  1.50E+3nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302684((S)-5-oxo-4-(6-(4-(2-oxo-2-(pyrrolidin-1-yl)ethyl)...)
Affinity DataIC50:  1.50E+3nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302699((S)-5-(4-(butoxycarbonyl)piperazin-1-yl)-4-(6-(4-(...)
Affinity DataIC50:  1.50E+3nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302689((S)-5-(4-(butoxycarbonyl)piperazin-1-yl)-5-oxo-4-(...)
Affinity DataIC50:  1.50E+3nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302687((S)-4-(6-(4-(2-(ethylamino)-2-oxoethyl)piperidin-1...)
Affinity DataIC50:  1.60E+3nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302702((S)-5-oxo-4-(6-(4-((2-oxopyrrolidin-1-yl)methyl)pi...)
Affinity DataIC50:  1.60E+3nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302638((S)-4-(6-(4-(dimethylcarbamoyl)piperazin-1-yl)-2-p...)
Affinity DataIC50:  1.60E+3nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302666((S)-5-oxo-5-(4-(pentyloxycarbonyl)piperazin-1-yl)-...)
Affinity DataIC50:  1.70E+3nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302717((S)-5-oxo-5-(4-(pentyloxycarbonyl)piperazin-1-yl)-...)
Affinity DataIC50:  1.70E+3nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302668((S)-5-(4-(butoxycarbonyl)piperazin-1-yl)-4-(6-(1-i...)
Affinity DataIC50:  1.80E+3nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50302716((S)-5-(4-(butoxycarbonyl)piperazin-1-yl)-4-(6-(4-m...)
Affinity DataIC50:  1.80E+3nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 105 total ) | Next | Last >>
Jump to: